Resources

Issuance volume

11.30.2023 ABS Totals

Issuance volume of asset-backed securities for the year through November 30, 2023

November 30
League tables

11.30.23 ABS League Tables

Underwriting league tables of asset-backed securities through November 30, 2023

November 30
League tables

11.23.23 ABS League Tables

Underwriting league tables of asset-backed securities through November 23, 2023

November 23
Issuance volume

11.23.2023 ABS Totals

Issuance volume of asset-backed securities for the year through November 23, 2023

November 23
League tables

11.16.23 ABS League Tables

Underwriting league tables of asset-backed securities through November 16, 2023

November 16
Issuance volume

11.16.2023 ABS Totals

Issuance volume of asset-backed securities for the year through November 16, 2023

November 16
Biologics and benefit plans: What employers need to know

Biologics are one of the fastest growing category of drugs—and one of the most expensive—making it challenging to balance cost with safety and efficacy. And it's even more challenging to incorporate unbranded biologics and biosimilars into benefits plans.

Partner Insights from Janssen
League tables

11.9.23 ABS League Tables

Underwriting league tables of asset-backed securities through November 9, 2023

November 9
Issuance volume

11.9.2023 ABS Totals

Issuance volume of asset-backed securities for the year through November 9, 2023

November 9
League tables

11.2.23 ABS League Tables

Underwriting league tables of asset-backed securities through November 2, 2023

November 2